Download presentation
Presentation is loading. Please wait.
Published byFranklin Malone Modified over 9 years ago
1
Knowledge and Attitudes Toward Genetic Testing in Parkinson’s Disease Dana Lundberg 2006
2
Parkinson’s Disease Is a degenerative neurological disorder Affects the substantia nigra, the part of the brain that controls movement Includes three symptoms: a resting tremor rigidity bradykinesia (slowness) Substantia Nigra www.nlm.nih.gov/medlineplus/enc y/imagepages/19515.htm
3
Parkinson’s disease is divided into two onset categories: Young-onset (less than 50 years at onset) Old-onset (50 years or older at onset) Onset Categories
4
Objectives To identify attitudes Parkinson’s disease patients have toward diagnostic, predictive, and prenatal genetic testing To identify the resources most used by patients for information on Parkinson’s disease To assess the level of knowledge patients have about the genetics of Parkinson’s disease
5
Genetics of Parkinson’s Studies by Healy et al. (2004), Toft et al. (2005), and Hattori et al. (2004) revealed several gene mutations Genes that mutations have been identified in: - parkin - PINK1 - DJ-1 - α-Synuclein - LRKK2 Clinical genetic testing for the parkin and PINK1 genes is available
6
Rationale Prior to wide spread use of genetic testing for Parkinson’s disease researchers need to be aware of: The interest level in genetic testing The level of knowledge patients have of genetic testing Where to target educational programs for genetic testing
7
Jacobs et al. showed attitudes toward genetic testing in a young-onset Parkinson’s population: 72% of subjects indicated that they would take a presymptomatic genetic test 57% were interested in the availability of a prenatal genetic test for Parkinson’s My study differs: It included both young and old-onset patients It included questions regarding sources of information and knowledge about the genetics of Parkinson’s Background
8
Hypothesis Patients with Parkinson’s disease will respond with a positive attitude toward diagnostic, predictive, and prenatal genetic testing for the disease.
9
Struthers Parkinson’s Center (n = 58) National Parkinson Foundation’s Young-Onset Conference in Phoenix, AZ (n = 39) Struthers Parkinson’s Center (Golden Valley, MN) Young-Onset Parkinson’s Conference (Phoenix, AZ) Survey Sites
10
Survey Demographics General knowledge about: Parkinson’s disease genetics genetics of Parkinson’s disease Sources of information on Parkinson’s disease Attitudes toward: diagnostic genetic testing predictive genetic testing prenatal genetic testing genetic testing at 100%, 90%, and 60% genetic risk
11
Data Analysis Data were tabulated in an Excel spreadsheet Data were analyzed using descriptive and nonlinear (chi-squared) statistics P-values were considered significant when p ≤ 0.050
12
Distribution of Age of Onset
13
Distribution of Gender
14
Education Levels of Subject Population 19% 16% 65%
15
Distribution of Subjects with Relatives Diagnosed with Parkinson’s 79% 21%
16
Sources of Information P<0.001
17
Sources of Information P<0.001
18
Sources of Information P<0.001
19
Sources of Information P=0.040
20
Knowledge about Parkinson's and genetics: Number answering correctly (%) Knowledge Questions: < 50 years at onset n (%) ≥ 50 years at onset n (%) Total (%)p-value Parkinson's Disease Knowledge Questions: Parkinson’s disease is less common in people who smoke. 16 (35%)10 (20%)27%p = 0.090 Parkinson’s disease always begins after age 50. 45 (98%)46 (90%)94%p = 0.120 Parkinson’s disease is caused by a problem in brain cells that use dopamine. 44 (96%)44 (86%)91%p = 0.110 There is a gene therapy treatment that can cure Parkinson’s disease. 45 (98%)47 (92%)95%p = 0.210 There is an over-the counter, “natural” treatment that can cure Parkinson’s disease. 46 (100%)48 (94%)97%p = 0.090 Specific Genetic Questions: A gene is composed of a group of proteins. 9 (20%)4 (8%)13%p = 0.090 Genetic diseases always begin in childhood. 39 (85%)40 (78%)81%p = 0.440 It is possible to have an abnormal gene without having symptoms of a disease.43 (93%)39 (76%)85%p = 0.020 The Genetics of Parkinson's Disease Questions: Parkinson’s disease can be caused by a mutation in a gene called parkin.16 (35%)4 (8%)21%p < 0.001 Scientists have identified genes that are associated with a higher risk of Parkinson’s disease.30 (65%)19 (37%)51%p = 0.005 There is a gene test that can identify who will get Parkinson’s disease. 9 (20%)16 (31%)26%p = 0.180
21
Knowledge about Parkinson's and genetics: Number answering correctly (%) Knowledge Questions: < 50 years at onset n (%) ≥ 50 years at onset n (%) Total (%)p-value Parkinson's Disease Knowledge Questions: Parkinson’s disease is less common in people who smoke. 16 (35%)10 (20%)27%p = 0.090 Parkinson’s disease always begins after age 50. 45 (98%)46 (90%)94%p = 0.120 Parkinson’s disease is caused by a problem in brain cells that use dopamine. 44 (96%)44 (86%)91%p = 0.110 There is a gene therapy treatment that can cure Parkinson’s disease. 45 (98%)47 (92%)95%p = 0.210 There is an over-the counter, “natural” treatment that can cure Parkinson’s disease. 46 (100%)48 (94%)97%p = 0.090 Specific Genetic Questions: A gene is composed of a group of proteins. 9 (20%)4 (8%)13%p = 0.090 Genetic diseases always begin in childhood. 39 (85%)40 (78%)81%p = 0.440 It is possible to have an abnormal gene without having symptoms of a disease.43 (93%)39 (76%)85%p = 0.020 The Genetics of Parkinson's Disease Questions: Parkinson’s disease can be caused by a mutation in a gene called parkin.16 (35%)4 (8%)21%p < 0.001 Scientists have identified genes that are associated with a higher risk of Parkinson’s disease.30 (65%)19 (37%)51%p = 0.005 There is a gene test that can identify who will get Parkinson’s disease. 9 (20%)16 (31%)26%p = 0.180
22
Knowledge about Parkinson's and genetics: Number answering correctly (%) Knowledge Questions: < 50 years at onset n (%) ≥ 50 years at onset n (%) Total (%)p-value Parkinson's Disease Knowledge Questions: Parkinson’s disease is less common in people who smoke. 16 (35%)10 (20%)27%p = 0.090 Parkinson’s disease always begins after age 50. 45 (98%)46 (90%)94%p = 0.120 Parkinson’s disease is caused by a problem in brain cells that use dopamine. 44 (96%)44 (86%)91%p = 0.110 There is a gene therapy treatment that can cure Parkinson’s disease. 45 (98%)47 (92%)95%p = 0.210 There is an over-the counter, “natural” treatment that can cure Parkinson’s disease. 46 (100%)48 (94%)97%p = 0.090 Specific Genetic Questions: A gene is composed of a group of proteins. 9 (20%)4 (8%)13%p = 0.090 Genetic diseases always begin in childhood. 39 (85%)40 (78%)81%p = 0.440 It is possible to have an abnormal gene without having symptoms of a disease.43 (93%)39 (76%)85%p = 0.020 The Genetics of Parkinson's Disease Questions: Parkinson’s disease can be caused by a mutation in a gene called parkin.16 (35%)4 (8%)21%p < 0.001 Scientists have identified genes that are associated with a higher risk of Parkinson’s disease.30 (65%)19 (37%)51%p = 0.005 There is a gene test that can identify who will get Parkinson’s disease. 9 (20%)16 (31%)26%p = 0.180
23
Attitudes toward Genetic Testing: Number answering "yes" (%) Questions < 50 years at onset n (%) ≥ 50 years at onset n (%) Total (%)p-value Diagnostic Genetic Testing: Would you take this test? 100% genetic risk33 (72%)44 (86%)79%p = 0.250 90% genetic risk 33 (72%)41 (80%)76%p = 0.250 60% genetic risk23 (50%)34 (67%)59%p = 0.100 Predictive Genetic Testing: Do you think this genetic test should be offered to people without symptoms of Parkinson’s disease? 100% genetic risk36 (78%)34 (67%)72%p = 0.250 90% genetic risk32 (70%)25 (49%)59%p = 0.050 60% genetic risk 26 (57%)25 (49%)53%p = 0.500 Prenatal Genetic Testing: Do you think a prenatal genetic test should be offered to pregnant mothers? 100% genetic risk23 (50%) 17 (33%)41%p = 0.100 90% genetic risk23 (50%)15 (29%)39%p = 0.050 60% genetic risk21 (46%)13 (25%)35%p = 0.050
24
Attitudes toward Genetic Testing: Number answering "yes" (%) Questions < 50 years at onset n (%) ≥ 50 years at onset n (%) Total (%)p-value Diagnostic Genetic Testing: Would you take this test? 100% genetic risk33 (72%)44 (86%)79%p = 0.250 90% genetic risk 33 (72%)41 (80%)76%p = 0.250 60% genetic risk23 (50%)34 (67%)59%p = 0.100 Predictive Genetic Testing: Do you think this genetic test should be offered to people without symptoms of Parkinson’s disease? 100% genetic risk36 (78%)34 (67%)72%p = 0.250 90% genetic risk32 (70%)25 (49%)59%p = 0.050 60% genetic risk 26 (57%)25 (49%)53%p = 0.500 Prenatal Genetic Testing: Do you think a prenatal genetic test should be offered to pregnant mothers? 100% genetic risk23 (50%) 17 (33%)41%p = 0.100 90% genetic risk23 (50%)15 (29%)39%p = 0.050 60% genetic risk21 (46%)13 (25%)35%p = 0.050
25
Attitudes toward Genetic Testing: Number answering "yes" (%) Questions < 50 years at onset n (%) ≥ 50 years at onset n (%) Total (%)p-value Diagnostic Genetic Testing: Would you take this test? 100% genetic risk33 (72%)44 (86%)79%p = 0.250 90% genetic risk 33 (72%)41 (80%)76%p = 0.250 60% genetic risk23 (50%)34 (67%)59%p = 0.100 Predictive Genetic Testing: Do you think this genetic test should be offered to people without symptoms of Parkinson’s disease? 100% genetic risk36 (78%)34 (67%)72%p = 0.250 90% genetic risk32 (70%)25 (49%)59%p = 0.050 60% genetic risk 26 (57%)25 (49%)53%p = 0.500 Prenatal Genetic Testing: Do you think a prenatal genetic test should be offered to pregnant mothers? 100% genetic risk23 (50%) 17 (33%)41%p = 0.100 90% genetic risk23 (50%)15 (29%)39%p = 0.050 60% genetic risk21 (46%)13 (25%)35%p = 0.050
26
Discussion Overall the attitudes expressed towards diagnostic, predictive, and prenatal genetic testing were positive 1.A majority (≥ 50%) of patients expressed positive attitudes toward diagnostic genetic testing at all three levels of genetic risk 2.Young-onset patients expressed positive attitudes toward predictive genetic testing slightly more, but not significantly more, than old-onset patients at all three levels of genetic risk 3.Young-onset patients expressed positive attitudes toward prenatal genetic testing significantly more than old-onset at the 90% and 60% levels of genetic risk (p = 0.050 for both tests)
27
Most commonly used source of information was a neurologist Young-onset subjects used the internet significantly more than old-onset (p < 0.001) Young-onset subjects used lay organizations and support groups/conferences significantly more than the old-onset subjects (p < 0.001 for both resources) a majority of the young-onset subjects were interviewed at a National Parkinson Foundation conference Young-onset subjects were significantly more knowledgeable about the genetics of Parkinson’s (p < 0.001 and p = 0.005) Number of patients that correctly answered questions in both the young-onset and, especially, the old-onset groups was low Discussion
28
Applications Educational programmers: What aspects of Parkinson’s and genetics to focus programs Where to publish information to best educate the Parkinson’s community about genetic testing Pharmaceutical companies: What populations to target for genetic testing At what levels of genetic risk patients may be interested in taking genetic tests
29
Future Work Larger subject population through a mailed survey Redesign survey to include reasons for accepting or rejecting genetic testing Conduct at a conference oriented toward old-onset or both onset groups
30
Acknowledgements Dr. Martha Nance Catherine Wielinski Ms. Fruen 2005-06 Research Team
31
Knowledge and Attitudes Toward Genetic Testing in Parkinson’s Disease Dana Lundberg 2006
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.